1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. 製品タイプ別スニペット
3.2. 年齢層別スニペット
3.3. エンドユーザー別スニペット
3.4. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 心血管疾患（CVDs）の有病率の増加と技術の進歩
4.1.2. 阻害要因
4.1.2.1. 製品回収
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
6. 製品タイプ別
6.1. 製品紹介
6.1.1. 製品タイプ別市場規模分析および前年比成長率分析(%)
6.1.2. 市場魅力度指数（製品タイプ別
6.2. 植込み型除細動器（ICD）*市場
6.2.1. 序論
6.2.2. 市場規模分析と前年比成長率分析(%)
6.2.3. 経静脈植込み型除細動器（T-ICDs）
6.2.4. 皮下植込み型除細動器（S-ICD）
6.2.5. 心臓再同期療法除細動器（CRT-D）
6.3. 体外式除細動器
6.3.1. 手動式体外式除細動器
6.3.2. 装着型除細動器
6.3.3. 自動体外式除細動器（AED）
6.3.3.1. 半自動AED
6.3.3.2. 全自動AED
7. 年齢層別
7.1. はじめに
7.1.1. 市場規模分析および前年比成長率分析（%）, 年齢層別
7.1.2. 市場魅力度指数（年齢層別
7.2. 小児科
7.2.1. 序論
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. 大人
8. エンドユーザー別
8.1. はじめに
8.1.1. 市場規模分析および前年比成長率分析(%), エンドユーザー別
8.1.2. 市場魅力度指数、エンドユーザー別
8.2. 病院
8.2.1. はじめに
8.2.2. 市場規模分析と前年比成長率分析(%)
8.3. 心臓センター
8.4. 在宅医療
8.5. その他
9. 地域別
9.1. はじめに
9.1.1. 地域別市場規模分析および前年比成長率分析(%)
9.1.2. 市場魅力度指数、地域別
9.2. 北米
9.2.1. 序論
9.2.2. 主な地域別ダイナミクス
9.2.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.2.4. 市場規模分析および前年比成長率分析（%）：年齢層別
9.2.5. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
9.2.6. 市場規模分析および前年比成長率分析（%）, 国別
9.2.6.1. 米国
9.2.6.2. カナダ
9.2.6.3. メキシコ
9.3. ヨーロッパ
9.3.1. はじめに
9.3.2. 主な地域別動向
9.3.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.3.4. 市場規模分析および前年比成長率分析（%）：年齢層別
9.3.5. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
9.3.6. 市場規模分析および前年比成長率分析（%）, 国別
9.3.6.1. ドイツ
9.3.6.2. イギリス
9.3.6.3. フランス
9.3.6.4. スペイン
9.3.6.5. イタリア
9.3.6.6. その他のヨーロッパ
9.4. 南米
9.4.1. はじめに
9.4.2. 地域別主要市場
9.4.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.4.4. 市場規模分析および前年比成長率分析（%）：年齢層別
9.4.5. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
9.4.6. 市場規模分析および前年比成長率分析（%）, 国別
9.4.6.1. ブラジル
9.4.6.2. アルゼンチン
9.4.6.3. その他の南米諸国
9.5. アジア太平洋
9.5.1. はじめに
9.5.2. 主な地域別ダイナミクス
9.5.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.5.4. 市場規模分析および前年比成長率分析（%）：年齢層別
9.5.5. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
9.5.6. 市場規模分析および前年比成長率分析（%）, 国別
9.5.6.1. 中国
9.5.6.2. インド
9.5.6.3. 日本
9.5.6.4. 韓国
9.5.6.5. その他のアジア太平洋地域
9.6. 中東・アフリカ
9.6.1. 序論
9.6.2. 主な地域別ダイナミクス
9.6.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.6.4. 市場規模分析および前年比成長率分析（%）：年齢層別
9.6.5. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10. 競合情勢
10.1. 競争シナリオ
10.2. 市場ポジショニング／シェア分析
10.3. M&A分析
11. 企業プロフィール
11.1. Medtronic*
11.1.1. 会社概要
11.1.2. 製品ポートフォリオと内容
11.1.3. 財務概要
11.1.4. 主な展開
11.2. Boston Scientific Corporation
11.3. Abbott
11.4. Koninklijke Philips N.V.
11.5. Stryker
11.6. NIHON KOHDEN CORPORATION
11.7. Mindray Medical India Pvt. Ltd.
11.8. MicroPort Scientific Corporation.
11.9. ZOLL Medical Corporation
11.10. Biotronik（※リストは除く）
12. 付録
12.1. 会社概要とサービス
12.2. お問い合わせ
The Global Defibrillators Market reached US$ 12.88 billion in 2023 and is expected to reach US$ 22.29 billion by 2031 growing with a CAGR of 7.1%% during the forecast period 2024-2031.
Defibrillators are critical medical devices that deliver an electric shock or pulse to the heart to restore a normal heartbeat, particularly in cases of cardiac arrest, also known as sudden cardiac arrest (SCA). When the heart's rhythm ceases due to conditions such as ventricular fibrillation or pulseless ventricular tachycardia, a defibrillator can help restart the heart. A sudden cardiac arrest is fatal unless treated immediately with cardiopulmonary resuscitation (CPR) and the use of a defibrillator.
Defibrillators function by delivering an electric shock to the heart muscle. This shock depolarizes a significant portion of the heart tissue, effectively disrupting the disordered electrical activity that leads to arrhythmias. The primary aim is to reset the heart's electrical system, enabling it to regain a normal rhythm. The main arrhythmias that defibrillators target are ventricular fibrillation and pulseless ventricular tachycardia.
Market Dynamics: Drivers
Increasing prevalence of cardiovascular diseases (CVDs) and technological advancements
The demand for the global defibrillators market is driven by multiple factors. One of the key factors is the increasing prevalence of cardiovascular diseases (CVDs) and technological advancements. Cardiovascular diseases (CVDs) are the foremost cause of death worldwide. The increasing occurrence of cardiovascular diseases (CVDs), such as coronary artery disease and heart failure, is a major factor driving the growth of the defibrillator market.
According to the WHO data in May 2024, Cardiovascular diseases (CVDs) are the primary cause of disability and premature death in the European Region, accounting for over 42.5% of all annual deaths, which translates to approximately 10,000 fatalities each day. As per the report from WHO/Europe, men in this region are nearly 2.5 times more likely to succumb to CVD compared to women.
Additionally, there is a marked geographic disparity; the likelihood of dying young (between the ages of 30 and 69) from a CVD is almost five times greater in Eastern Europe and Central Asia than in Western Europe. With cardiovascular diseases (CVDs) being the foremost cause of death and disability in Europe, there is an urgent requirement for immediate access to defibrillation during cardiac emergencies.
Moreover, continuous innovations in defibrillator technology are significantly enhancing device efficiency and user-friendliness, which is crucial for improving patient outcomes during cardiac emergencies. Modern defibrillators, particularly Implantable Cardioverter Defibrillators (ICDs) and Automated External Defibrillators (AEDs), now incorporate advanced features that facilitate better monitoring and treatment of patients at risk of sudden cardiac arrest.
In addition, government initiatives such as awareness programs and the introduction of innovative product launches are driving this market growth. For instance, in July 2023, the Uttar Pradesh government announced a significant initiative to improve public health by installing Automated External Defibrillators (AEDs) in all government buildings, malls, and other public places, including the Uttar Pradesh Secretariat. This initiative aims to provide essential first aid to individuals experiencing cardiac arrest.
Also, in January 2023, Mindray announced the launch of its next-generation BeneHeart series defibrillators, specifically the BeneHeart D60 and D30 models. These advanced devices are designed to elevate the standards of resuscitation by offering superior reliability, comprehensive diagnostic capabilities, and monitoring tools. The introduction of these defibrillators aims to provide a complete quality improvement solution for both in-hospital and pre-hospital emergencies.
Restraints
Factors such as product recalls, the high cost of devices, concerns associated with the usage of devices, lack of skilled professionals, and regulatory challenges are expected to hamper the market.
Market Segment Analysis
The global defibrillators market is segmented based on product type, age group, end-user, and region.
The external defibrillators segment accounted for approximately 73.3% of the global defibrillators market share
The external defibrillators segment is expected to hold the largest market share over the forecast period. External defibrillators are medical devices designed to deliver an electric shock to the heart to restore its normal rhythm during life-threatening cardiac arrhythmias, such as ventricular fibrillation and pulseless ventricular tachycardia.
These devices are essential for treating sudden cardiac arrest (SCA), a condition where the heart unexpectedly stops functioning effectively. External defibrillators include manual external defibrillators, wearable cardioverter defibrillators, and automated external defibrillators (AEDs).
Moreover, key players in the region, product launches, and awareness programs help to propel this segment's growth in the market. For instance, in March 2024, Stryker, a leading global medical technology company, participated in the Criticare National Conference, which took place at the ITC Royal Bengal in Kolkata, India. During this event, Stryker launched and showcased two innovative products: LIFEPAK CR2 automated external defibrillator (AED) and the Evacuation Chair designed for emergency patient evacuation.
The LIFEPAK CR2 is an innovative defibrillator that empowers rescuers to deliver high-quality CPR and provide immediate shocks during sudden cardiac arrest (SCA) emergencies. This revolutionary device is designed to enhance the ability of rescuers to provide life-saving care to victims of sudden cardiac arrest.
Similarly, in January 2024, Speedy Hire initiated a life-saving program to equip its engineer vans across the UK with Automated External Defibrillators (AEDs). The rollout starts with the installation of 18 defibrillators, with plans to expand this to over 300 portable devices in the vans of Speedy Hire's engineers. This initiative aims to address the concerning statistic that more than 30,000 individuals in the UK suffer from out-of-hospital cardiac arrests annually, with less than 10% surviving. By providing AEDs in their vans, Speedy Hire intends to enhance immediate response capabilities during emergencies, ensuring that help is readily available when needed.
Market
Geographical Analysis
North America accounted for approximately 43.7% of the global defibrillators market share
North America region is expected to hold the largest market share over the forecast period owing to the increasing occurrence of cardiovascular diseases, such as heart attack, heart failure, and coronary heart disease, which is a significant driver of market growth in North America.
Heart disease is the primary cause of mortality for men, and women, in the United States. In 2022, cardiovascular disease claimed the lives of 702,880 people, which translates to one death every 33 seconds and accounts for approximately one out of every five deaths nationwide.
Moreover, awareness campaigns and government initiatives propel the significance of automated external defibrillators (AEDs) fueling market growth in North America. Numerous states in the U.S. have enacted laws mandating the installation of AEDs in specific public locations, including highway rest areas, government buildings, public safety vehicles, hotels, urgent care centers, and retail health clinics.
Additionally, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, technological advancements, and product launches & approvals would propel this Market growth. For instance, in October 2023, Medtronic received FDA approval for its Aurora Extravascular Implantable Cardioverter Defibrillator (EV-ICD), an innovative device designed to treat abnormal heart rhythms and prevent sudden cardiac arrest (SCA). This innovative defibrillator represents a significant advancement in cardiac care technology.
Also, in January 2023, Avive Solutions received pre-market approval (PMA) from the U.S. Food and Drug Administration (FDA) for its innovative Avive AED, a unique Automated External Defibrillator (AED). This approval signifies a major advancement in cardiac emergency response technology.
The Avive AED is a pioneering device that integrates cellular, WiFi, GPS, and Bluetooth connectivity into a compact, handheld format. This suite of connectivity features powers Avive's groundbreaking REALConnect Technology, which is designed to seamlessly connect with 911 emergency centers through a collaboration with RapidSOS. As a result, the device can transmit critical incident data to 911 dispatchers, emergency medical services (EMS), and healthcare professionals in real-time, enhancing situational awareness and optimizing emergency response efforts.
Market Segmentation
By Product Type
Implantable Cardioverter Defibrillators (ICDs)
Transvenous Implantable Cardioverter Defibrillators (T-ICDs)
Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
Cardiac Resynchronization Therapy Defibrillators (CRT-D)
External Defibrillators
Manual External Defibrillators
Wearable Cardioverter Defibrillators
Automated External Defibrillators (AEDs)
Semi-Automated AEDs
Fully Automated AEDs
By Age Group
Pediatrics
Adults
By End-User
Hospitals
Cardiac Centers
Homecare Settings
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
South America
Brazil
Argentina
The rest of South America
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Middle East and Africa
Market Competitive Landscape
The major global players in the defibrillators market include Medtronic, Boston Scientific Corporation, Abbott, Koninklijke Philips N.V., Stryker, NIHON KOHDEN CORPORATION, Mindray Medical India Pvt. Ltd., MicroPort Scientific Corporation., ZOLL Medical Corporation, and Biotronik among others.
Key Developments
In June 2024, the launch of the first-ever Hato Hone St John branded defibrillators represents a significant advancement in emergency cardiac care technology. These new Automated External Defibrillators (AEDs), developed in partnership with medical technology manufacturer ViVest, are designed to deliver a shock to a patient in as little as seven seconds, which is crucial during sudden cardiac arrest (SCA) situations.
In May 2024, London Hearts, a leading defibrillator charity in the UK, announced the launch of a new scheme aimed at making defibrillators more accessible and affordable to communities across the country. The charity provides funding through grants to help organizations and communities acquire these life-saving devices. The scheme is a significant step towards making defibrillators more affordable and widely available throughout the UK.
In October 2023, MicroPort CRM announced the launch of the ULYS Implantable Cardioverter Defibrillator (ICDs) and INVICTA defibrillation lead in Japan. Both devices are MRI conditional at 1.5T and 3T when implanted as a system. This advanced technology ensures low current consumption, leading to a predicted lifespan that is up to 8 years longer than other ICD devices. Additionally, the ULYS incorporates the PARAD+ arrhythmia discrimination algorithm, which has been clinically proven to have the lowest rate of inappropriate shocks.
Why Purchase the Report?
To visualize the global defibrillators market segmentation based on product type, age group, end-user, and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the defibrillators market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in Excel consisting of key products of all the major players.
The global defibrillators market report would provide approximately 62 tables, 51 figures, and 183 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Age Group
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Prevalence of Cardiovascular Diseases (CVDs) And Technological Advancements
4.1.2. Restraints
4.1.2.1. Product Recalls
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Implantable Cardioverter Defibrillators (ICDs)*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Transvenous Implantable Cardioverter Defibrillators (T-ICDs)
6.2.4. Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
6.2.5. Cardiac Resynchronization Therapy Defibrillators (CRT-D)
6.3. External Defibrillators
6.3.1. Manual External Defibrillators
6.3.2. Wearable Cardioverter Defibrillators
6.3.3. Automated External Defibrillators (AEDs)
6.3.3.1. Semi-Automated AEDs
6.3.3.2. Fully Automated AEDs
7. By Age Group
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
7.1.2. Market Attractiveness Index, By Age Group
7.2. Pediatrics *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Adults
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cardiac Centers
8.4. Homecare Settings
8.5. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. U.K.
9.3.6.3. France
9.3.6.4. Spain
9.3.6.5. Italy
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Medtronic*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Boston Scientific Corporation
11.3. Abbott
11.4. Koninklijke Philips N.V.
11.5. Stryker
11.6. NIHON KOHDEN CORPORATION
11.7. Mindray Medical India Pvt. Ltd.
11.8. MicroPort Scientific Corporation.
11.9. ZOLL Medical Corporation
11.10. Biotronik (*LIST NOT EXHAUSTIVE)
12. Appendix
12.1. About Us and Services
12.2. Contact Us
| ※参考情報 除細動器は心臓の不整脈や心室細動といった状態に対処するために使用される医療機器です。これらの状態は、心臓が正常に血液を拍出できなくなり、命に関わる緊急事態を引き起こすことがあります。除細動器は、電気的なショックを心臓に与えることで正常なリズムを取り戻す役割を果たします。この機器は、医療現場のみならず、一般の人々が使用できるように製造されたものも多く、心臓突然死のリスクを低減する重要なツールとなっています。 除細動器には主に二つの種類があります。ひとつは自動体外式除細動器（AED）で、もうひとつは病院や救急救命士によって使用される内因性除細動器です。AEDは一般市民が使用できるように設計されており、音声ガイダンスや視覚的な指示に従って操作を行うことができます。このため、心停止が疑われる際に迅速に対応できるのが特長です。一方、内因性除細動器は、病院内で使用される高性能な機器です。これには多様なモードがあり、医療従事者によって操作され、心拍数やその他の生理的なパラメータをモニタリングしながら適切な治療を行います。 除細動器の用途は主に心臓の不整脈治療ですが、特に心室細動や無脈性電気活動（PEA）において、生死を分ける重要な役割を持っています。迅速な除細動が行われることで、心筋が再び正常なリズムに戻り、血流が再開する可能性が高まります。このため、除細動器は公共の場や学校、スポーツ施設、企業など、さまざまな場所に設置されており、一般の人々が使用できるようなトレーニングも行われています。 関連技術としては、心電図（ECG）モニタリングがあります。除細動器は心電図を解析し、除細動が必要かどうかを判断します。これにより、誤った操作を防ぎ、患者の安全性が確保されます。また、最新のAEDはスマートフォンと連携可能で、心停止が発生した場所への最短ルートを示すことができる機能を持つものもあります。このような進化した技術により、除細動器の効果がさらに高まっています。 加えて、除細動器の電気ショックの強度やタイミングも重要な要素です。適切なショックエネルギーが選択されることで、心臓のリズムを効果的に回復させることができます。医療機関では、患者の状態に応じた複数の電気ショックプログラムが用意されており、これにより患者の救命率を向上させることができます。 心臓の健康を維持するためには、除細動器の使用だけでなく、日常的な健康管理も重要です。健全な生活習慣を保ち、定期的な健康診断を受けることは心臓病を予防する一助となります。また、除細動器についての教育や啓発活動も進められており、一般の人々が心停止に対して適切に対応できる知識を持つことが求められています。 以上のように、除細動器は心臓病治療において非常に重要な役割を果たしており、その種類や用途、関連技術についての理解を深めることが、心臓突然死の予防に繋がります。今後も技術の進歩が期待される中、除細動器はますます多くの人々の命を救う手段となるでしょう。医療現場だけでなく、一般市民にも利用が広がることで、社会全体で心臓病に立ち向かう姿勢が強化されることが重要です。 |
*** 除細動器の世界市場に関するよくある質問(FAQ) ***
・除細動器の世界市場規模は？
→DataM Intelligence社は2023年の除細動器の世界市場規模を128.8億米ドルと推定しています。
・除細動器の世界市場予測は？
→DataM Intelligence社は2031年の除細動器の世界市場規模を222.9億米ドルと予測しています。
・除細動器市場の成長率は？
→DataM Intelligence社は除細動器の世界市場が2024年～2031年に年平均7.1%成長すると展望しています。
・世界の除細動器市場における主要プレイヤーは？
→「Medtronic、Boston Scientific Corporation、Abbott、Koninklijke Philips N.V.、Stryker、NIHON KOHDEN CORPORATION、Mindray Medical India Pvt. Ltd.、MicroPort Scientific Corporation、ZOLL Medical Corporation、Biotronikなど ...」を除細動器市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
